Skip to main content
Erschienen in: Clinical Orthopaedics and Related Research® 5/2008

01.05.2008 | Symposium: Molecular and Surgical Advances in Osteonecrosis

Genetic Background of Nontraumatic Osteonecrosis of the Femoral Head in the Korean Population

verfasst von: Jun-Dong Chang, MD, PhD, Mina Hur, MD, PhD, Sang-Soo Lee, MD, PhD, Je-Hyun Yoo, MD, Kyu Man Lee, MD, PhD

Erschienen in: Clinical Orthopaedics and Related Research® | Ausgabe 5/2008

Einloggen, um Zugang zu erhalten

Abstract

Major thrombophilic mutations have been identified as risk factors for nontraumatic osteonecrosis of the femoral head (ONFH) in Caucasians. We asked whether the genetic background of patients with ONFH in the Korean population was similar. We analyzed factor V G1691A mutation (factor V Leiden), prothrombin G20210A mutation, and methylenetetrahydrofolate reductase C677T and A1298C polymorphisms in 71 patients (53 men, 18 women) with ONFH. We classified these patients as 51 alcohol-induced, 18 idiopathic, one steroid-induced, and one dysbaric. We recruited 200 normal control subjects (128 men, 72 women). We used multiplex PCR/restriction fragment length polymorphism for each genotyping. We observed neither factor V Leiden nor prothrombin G20210A mutation. Although methylenetetrahydrofolate reductase A1298C genotypes were not associated with osteonecrosis, methylenetetrahydrofolate reductase C677T variant genotypes increased the risk of ONFH compared with 677CC. Odds ratios of 677CT and 677CT+TT were 2.00 (95% confidence interval, 1.05–3.81) and 1.96 (95% confidence interval, 1.07–3.59), respectively, compared with 677CC. Our data suggest methylenetetrahydrofolate reductase C677T polymorphism plays a role in the pathogenesis of osteonecrosis in the Korean population. It also implies the genetic risk profile of ONFH may differ among ethnic populations.
Level of Evidence: Level II, diagnostic study. See the Guidelines for Authors for a complete description of levels of evidence.
Literatur
1.
Zurück zum Zitat Angchaisuksiri P, Pingsuthiwong S, Aryuchai K, Busabaratana M, Sura T, Atichartakarn V, Sritara P. Prevalence of the G1691A mutation in the factor V gene (factor V Leiden) and the G21210A prothrombin gene mutation in the Thai population. Am J Hematol. 2000;65:119–122.PubMedCrossRef Angchaisuksiri P, Pingsuthiwong S, Aryuchai K, Busabaratana M, Sura T, Atichartakarn V, Sritara P. Prevalence of the G1691A mutation in the factor V gene (factor V Leiden) and the G21210A prothrombin gene mutation in the Thai population. Am J Hematol. 2000;65:119–122.PubMedCrossRef
2.
Zurück zum Zitat Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994;369:64–67.PubMedCrossRef Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994;369:64–67.PubMedCrossRef
3.
Zurück zum Zitat Bjorkman A, Burtscher IM, Svensson PJ, Hillarp A, Besjakov J, Benoni G. Factor V Leiden and the prothrombin 20210A gene mutation and osteonecrosis of the knee. Arch Orthop Trauma Surg. 2005;125:51–55.PubMedCrossRef Bjorkman A, Burtscher IM, Svensson PJ, Hillarp A, Besjakov J, Benoni G. Factor V Leiden and the prothrombin 20210A gene mutation and osteonecrosis of the knee. Arch Orthop Trauma Surg. 2005;125:51–55.PubMedCrossRef
4.
Zurück zum Zitat Bjorkman A, Svensson PJ, Hillarp A, Burtscher IM, Rünow A, Benoni G. Factor V Leiden and prothrombin gene mutation: risk factors for osteonecrosis of the femoral head in adults. Clin Orthop Relat Res. 2004;425:168–172.PubMedCrossRef Bjorkman A, Svensson PJ, Hillarp A, Burtscher IM, Rünow A, Benoni G. Factor V Leiden and prothrombin gene mutation: risk factors for osteonecrosis of the femoral head in adults. Clin Orthop Relat Res. 2004;425:168–172.PubMedCrossRef
5.
Zurück zum Zitat Chang JD, Lee SH, Oh SY, Wi YH, Lee JS. The risk factors associated with alcohol-induced osteonecrosis of the femoral head [in Korean]. J Korean Orthop Assoc. 2004;39:692–699. Chang JD, Lee SH, Oh SY, Wi YH, Lee JS. The risk factors associated with alcohol-induced osteonecrosis of the femoral head [in Korean]. J Korean Orthop Assoc. 2004;39:692–699.
6.
Zurück zum Zitat den Heijer M, Koster T, Blom HJ, Bos GM, Briet E, Reitsma PH, Vandenbroucke JP, Rosendaal FR. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med. 1996;334:759–762.CrossRef den Heijer M, Koster T, Blom HJ, Bos GM, Briet E, Reitsma PH, Vandenbroucke JP, Rosendaal FR. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med. 1996;334:759–762.CrossRef
7.
Zurück zum Zitat De Stefano V, Chiusolo P, Paciaroni K, Leone G. Epidemiology of factor V Leiden: clinical implications. Semin Thromb Hemost. 1998;24:367–379.PubMedCrossRef De Stefano V, Chiusolo P, Paciaroni K, Leone G. Epidemiology of factor V Leiden: clinical implications. Semin Thromb Hemost. 1998;24:367–379.PubMedCrossRef
8.
Zurück zum Zitat Gardeniers JWM. A new international classification of osteonecrosis of the ARCO Committee on terminology and classification. J Jpn Orthop Assoc. 1992;66:18–20. Gardeniers JWM. A new international classification of osteonecrosis of the ARCO Committee on terminology and classification. J Jpn Orthop Assoc. 1992;66:18–20.
9.
Zurück zum Zitat Glueck CJ, Freiberg RA, Fontaine RN, Tracy T, Wang P. Hypofibrinolysis, thrombophilia, osteonecrosis. Clin Orthop Relat Res. 2001;386:19–33.PubMedCrossRef Glueck CJ, Freiberg RA, Fontaine RN, Tracy T, Wang P. Hypofibrinolysis, thrombophilia, osteonecrosis. Clin Orthop Relat Res. 2001;386:19–33.PubMedCrossRef
10.
Zurück zum Zitat Glueck CJ, Freiberg RA, Tracy T, Stroop D, Wang P. Thrombophilia and hypofibrinolysis: pathophysiologies of osteonecrosis. Clin Orthop Relat Res. 1997;334:43–56.PubMedCrossRef Glueck CJ, Freiberg RA, Tracy T, Stroop D, Wang P. Thrombophilia and hypofibrinolysis: pathophysiologies of osteonecrosis. Clin Orthop Relat Res. 1997;334:43–56.PubMedCrossRef
11.
Zurück zum Zitat Han CD, Choe WS, Yoo JH. Effect of polyethylene wear on osteolysis in cementless primary total hip arthroplasty: minimal 5-year follow-up study. J Arthroplasty. 1999;14:714–723.PubMedCrossRef Han CD, Choe WS, Yoo JH. Effect of polyethylene wear on osteolysis in cementless primary total hip arthroplasty: minimal 5-year follow-up study. J Arthroplasty. 1999;14:714–723.PubMedCrossRef
12.
Zurück zum Zitat Hirota Y, Hotokebuchi T, Sugioka Y. Idiopathic osteonecrosis of the femoral head: nationwide epidemiologic studies in Japan. In: Urbiniak JR, Jones JP Jr, eds. Osteonecrosis: Etiology, Diagnosis, Treatment. Rosemont IL: American Academy of Orthopaedic Surgeons; 1997:51–58. Hirota Y, Hotokebuchi T, Sugioka Y. Idiopathic osteonecrosis of the femoral head: nationwide epidemiologic studies in Japan. In: Urbiniak JR, Jones JP Jr, eds. Osteonecrosis: Etiology, Diagnosis, Treatment. Rosemont IL: American Academy of Orthopaedic Surgeons; 1997:51–58.
13.
Zurück zum Zitat Hong SH, Song J, Kim JQ. Genetic variation of the methylenetetrahydrofolate reductase and cystathionine beta-synthase genes in Korean patients with coronary artery disease and a new polymorphism in intron 7. Mol Cell Probes. 2001;15:119–123.PubMedCrossRef Hong SH, Song J, Kim JQ. Genetic variation of the methylenetetrahydrofolate reductase and cystathionine beta-synthase genes in Korean patients with coronary artery disease and a new polymorphism in intron 7. Mol Cell Probes. 2001;15:119–123.PubMedCrossRef
14.
Zurück zum Zitat Hsu LA, Ko YL, Wang SM, Chang CJ, Hsu TS, Chiang CW, Lee YS. The C677T mutation of the methylenetetrahydrofolate reductase gene is not associated with the risk of coronary artery disease or venous thrombosis among Chinese in Taiwan. Hum Hered. 2001;51:41–45.PubMedCrossRef Hsu LA, Ko YL, Wang SM, Chang CJ, Hsu TS, Chiang CW, Lee YS. The C677T mutation of the methylenetetrahydrofolate reductase gene is not associated with the risk of coronary artery disease or venous thrombosis among Chinese in Taiwan. Hum Hered. 2001;51:41–45.PubMedCrossRef
15.
Zurück zum Zitat Jones LC, Mont MA, Le TB, Petri M, Hungerford DS, Wang P, Glueck CJ. Procoagulants and osteonecrosis. J Rheumatol. 2003;30:783–791.PubMed Jones LC, Mont MA, Le TB, Petri M, Hungerford DS, Wang P, Glueck CJ. Procoagulants and osteonecrosis. J Rheumatol. 2003;30:783–791.PubMed
16.
Zurück zum Zitat Jun ZJ, Ping T, Lei Y, Li L, Ming SY, Jing W. Prevalence of factor V Leiden and prothrombin G20210A mutations in Chinese patients with deep vein thrombosis and pulmonary embolism. Clin Lab Haematol. 2006;28:111–116.PubMedCrossRef Jun ZJ, Ping T, Lei Y, Li L, Ming SY, Jing W. Prevalence of factor V Leiden and prothrombin G20210A mutations in Chinese patients with deep vein thrombosis and pulmonary embolism. Clin Lab Haematol. 2006;28:111–116.PubMedCrossRef
17.
Zurück zum Zitat Kim YH, Kim VE. Uncemented porous-coated anatomic total hip replacement: results at six years in a consecutive series. J Bone Joint Surg Br. 1993;75:6–13.PubMed Kim YH, Kim VE. Uncemented porous-coated anatomic total hip replacement: results at six years in a consecutive series. J Bone Joint Surg Br. 1993;75:6–13.PubMed
18.
Zurück zum Zitat Kim YW, Yoon KY, Park S, Shim YS, Cho HI, Park SS. Absence of factor V Leiden mutation in Koreans. Thromb Res. 1997;86:181–182.PubMedCrossRef Kim YW, Yoon KY, Park S, Shim YS, Cho HI, Park SS. Absence of factor V Leiden mutation in Koreans. Thromb Res. 1997;86:181–182.PubMedCrossRef
19.
Zurück zum Zitat Lee JS, Koo KH, Ha YC, Koh KK, Kim SJ, Kim JR, Song HR, Cho SH. Role of thrombotic and fibrinolytic disorders in osteonecrosis of the femoral head. Clin Orthop Relat Res. 2003;417:270–276.PubMed Lee JS, Koo KH, Ha YC, Koh KK, Kim SJ, Kim JR, Song HR, Cho SH. Role of thrombotic and fibrinolytic disorders in osteonecrosis of the femoral head. Clin Orthop Relat Res. 2003;417:270–276.PubMed
20.
Zurück zum Zitat Lu Y, Zhao Y, Liu G, Wang X, Liu Z, Chen B, Hui R. Factor V gene G1691A mutation, prothrombin gene G20210A mutation, and MTHFR gene C677T mutation are not risk factors for pulmonary thromboembolism in Chinese population. Thromb Res. 2002;106:7–12.CrossRef Lu Y, Zhao Y, Liu G, Wang X, Liu Z, Chen B, Hui R. Factor V gene G1691A mutation, prothrombin gene G20210A mutation, and MTHFR gene C677T mutation are not risk factors for pulmonary thromboembolism in Chinese population. Thromb Res. 2002;106:7–12.CrossRef
21.
Zurück zum Zitat Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215–1218.PubMedCrossRef Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215–1218.PubMedCrossRef
22.
Zurück zum Zitat Salvati EA, Della Valle AG, Westrich GH, Rana AJ, Specht L, Weksler BB, Wang P, Glueck CJ. The John Charnley Award: heritable thrombophilia and development of thromboembolic disease after total hip arthroplasty. Clin Orthop Relat Res. 2005;441:40–55.PubMedCrossRef Salvati EA, Della Valle AG, Westrich GH, Rana AJ, Specht L, Weksler BB, Wang P, Glueck CJ. The John Charnley Award: heritable thrombophilia and development of thromboembolic disease after total hip arthroplasty. Clin Orthop Relat Res. 2005;441:40–55.PubMedCrossRef
23.
Zurück zum Zitat Wisotzkey JD, Bell T, Monk JS. Simultaneous polymerase chain reaction restriction fragment length polymorphism identification of the factor V Leiden allele and the prothrombin 20210A mutation. Diagn Mol Pathol. 1998;7:180–183.PubMedCrossRef Wisotzkey JD, Bell T, Monk JS. Simultaneous polymerase chain reaction restriction fragment length polymorphism identification of the factor V Leiden allele and the prothrombin 20210A mutation. Diagn Mol Pathol. 1998;7:180–183.PubMedCrossRef
24.
Zurück zum Zitat Yi P, Pogribny IP, James SJ. Multiplex PCR for simultaneous detection of 677 C→T and 1298 A→C polymorphisms in methylenetetrahydrofolate reductase gene for population studies of cancer risk. Cancer Lett. 2002;181:209–213.PubMedCrossRef Yi P, Pogribny IP, James SJ. Multiplex PCR for simultaneous detection of 677 C→T and 1298 A→C polymorphisms in methylenetetrahydrofolate reductase gene for population studies of cancer risk. Cancer Lett. 2002;181:209–213.PubMedCrossRef
25.
Zurück zum Zitat Zalavras C, Dailiana Z, Elisaf M, Bairaktari E, Vlachogiannopoulos P, Katsaraki A, Malizos KN. Potential aetiological factors concerning the development of osteonecrosis of the femoral head. Eur J Clin Invest. 2000;30:215–221.PubMedCrossRef Zalavras C, Dailiana Z, Elisaf M, Bairaktari E, Vlachogiannopoulos P, Katsaraki A, Malizos KN. Potential aetiological factors concerning the development of osteonecrosis of the femoral head. Eur J Clin Invest. 2000;30:215–221.PubMedCrossRef
26.
Zurück zum Zitat Zalavras CG, Malizos KN, Dokou E, Vartholomatos G. The 677C→T mutation of the methylene-tetrahydrofolate reductase gene in the pathogenesis of osteonecrosis of the femoral head. Haematologica. 2002;87:111–112.PubMed Zalavras CG, Malizos KN, Dokou E, Vartholomatos G. The 677C→T mutation of the methylene-tetrahydrofolate reductase gene in the pathogenesis of osteonecrosis of the femoral head. Haematologica. 2002;87:111–112.PubMed
27.
Zurück zum Zitat Zalavras CG, Vartholomatos G, Dokou E, Malizos KN. Factor V Leiden and prothrombin gene mutations in femoral head osteonecrosis. Thromb Haemost. 2002;87:1079–1080.PubMed Zalavras CG, Vartholomatos G, Dokou E, Malizos KN. Factor V Leiden and prothrombin gene mutations in femoral head osteonecrosis. Thromb Haemost. 2002;87:1079–1080.PubMed
28.
Zurück zum Zitat Zalavras CG, Vartholomatos G, Dokou E, Malizos KN. Genetic background of osteonecrosis. Associated with thrombophilic mutations? Clin Orthop Relat Res. 2004;422:251–255.PubMedCrossRef Zalavras CG, Vartholomatos G, Dokou E, Malizos KN. Genetic background of osteonecrosis. Associated with thrombophilic mutations? Clin Orthop Relat Res. 2004;422:251–255.PubMedCrossRef
Metadaten
Titel
Genetic Background of Nontraumatic Osteonecrosis of the Femoral Head in the Korean Population
verfasst von
Jun-Dong Chang, MD, PhD
Mina Hur, MD, PhD
Sang-Soo Lee, MD, PhD
Je-Hyun Yoo, MD
Kyu Man Lee, MD, PhD
Publikationsdatum
01.05.2008
Verlag
Springer-Verlag
Erschienen in
Clinical Orthopaedics and Related Research® / Ausgabe 5/2008
Print ISSN: 0009-921X
Elektronische ISSN: 1528-1132
DOI
https://doi.org/10.1007/s11999-008-0147-1

Weitere Artikel der Ausgabe 5/2008

Clinical Orthopaedics and Related Research® 5/2008 Zur Ausgabe

Symposium: Molecular and Surgical Advances in Osteonecrosis

Untreated Asymptomatic Hips in Patients With Osteonecrosis of the Femoral Head

Symposium: Molecular and Surgical Advances in Osteonecrosis

Extent of Osteonecrosis on MRI Predicts Humeral Head Collapse

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Arthroskopie kann Knieprothese nicht hinauszögern

25.04.2024 Gonarthrose Nachrichten

Ein arthroskopischer Eingriff bei Kniearthrose macht im Hinblick darauf, ob und wann ein Gelenkersatz fällig wird, offenbar keinen Unterschied.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 Leitsymptom Rückenschmerzen Nachrichten

Personen mit chronischen Rückenschmerzen, die von einfühlsamen Ärzten und Ärztinnen betreut werden, berichten über weniger Beschwerden und eine bessere Lebensqualität.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.